187 related articles for article (PubMed ID: 19640339)
1. Intravitreal steroid versus macular laser for treatment of diabetic macular edema.
Gunther J; Ip M
Curr Diab Rep; 2009 Aug; 9(4):272-6. PubMed ID: 19640339
[TBL] [Abstract][Full Text] [Related]
2. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
[TBL] [Abstract][Full Text] [Related]
3. Current intravitreal pharmacologic therapies for diabetic macular edema.
Colucciello M
Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
[TBL] [Abstract][Full Text] [Related]
4. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
Ajlan RS; Silva PS; Sun JK
Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
[TBL] [Abstract][Full Text] [Related]
5. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract.
Akinci A; Batman C; Ozkilic E; Altinsoy A
Retina; 2009; 29(10):1432-5. PubMed ID: 19898181
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and diabetic macular edema.
Lally DR; Shah CP; Heier JS
Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of intravitreal aflibercept in the treatment of diabetic macular edema in China.
Ming J; Zhang Y; Xu X; Zhao M; Wang Y; Chen Y; Zhang F; Wang J; Liu J; Zhao X; Han R; Hu S
J Comp Eff Res; 2020 Feb; 9(3):161-175. PubMed ID: 31904267
[No Abstract] [Full Text] [Related]
8. Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.
Dhoot DS; Avery RL
Curr Diab Rep; 2016 Dec; 16(12):122. PubMed ID: 27766582
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
Virgili G; Parravano M; Menchini F; Brunetti M
Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal Steroids in Diabetic Macular Edema.
Lattanzio R; Cicinelli MV; Bandello F
Dev Ophthalmol; 2017; 60():78-90. PubMed ID: 28427068
[TBL] [Abstract][Full Text] [Related]
11. Evolving strategies in the management of diabetic macular edema: clinical trials and current management.
Thomas BJ; Shienbaum G; Boyer DS; Flynn HW
Can J Ophthalmol; 2013 Feb; 48(1):22-30. PubMed ID: 23419295
[TBL] [Abstract][Full Text] [Related]
12. Update of intravitreal steroids for the treatment of diabetic macular edema.
Bandello F; Preziosa C; Querques G; Lattanzio R
Ophthalmic Res; 2014; 52(2):89-96. PubMed ID: 25195600
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.
Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH;
Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389
[TBL] [Abstract][Full Text] [Related]
14. [New perspectives in the approach to diabetic macular edema. Aflibercept therapy].
Ruiz-Moreno JM
Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():24-8. PubMed ID: 25925048
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor for diabetic macular oedema.
Virgili G; Parravano M; Menchini F; Evans JR
Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
[TBL] [Abstract][Full Text] [Related]
16. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone for the treatment of diabetic macular edema.
Gómez-Ulla F; Marticorena J; Alfaro DV; Fernández M; Méndez ER; Rothen M
Curr Diabetes Rev; 2006 Feb; 2(1):99-112. PubMed ID: 18220620
[TBL] [Abstract][Full Text] [Related]
18. Current treatment modalities in diabetic macular edema.
Choragiewicz T; Ozimek M; Nowomiejska K; Koss MJ; Juenemann AGM; Rejdak R
Klin Oczna; 2016 Sep; 117(4):267-270. PubMed ID: 29727116
[TBL] [Abstract][Full Text] [Related]
19. Aflibercept: A Review of Its Use in Diabetic Macular Oedema.
Keating GM
Drugs; 2015 Jul; 75(10):1153-60. PubMed ID: 26056030
[TBL] [Abstract][Full Text] [Related]
20. First-line treatment algorithm and guidelines in center-involving diabetic macular edema.
Kodjikian L; Bellocq D; Bandello F; Loewenstein A; Chakravarthy U; Koh A; Augustin A; de Smet MD; Chhablani J; Tufail A; García-Layana A; Sudhalkar A; Mathis T
Eur J Ophthalmol; 2019 Nov; 29(6):573-584. PubMed ID: 31238719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
